Top Markets
Coin of the day
Promore Pharma AB (publ) Promore Pharma AB (publ)

Promore Pharma AB (publ)

PROMO
Rang in aandelen #25506
Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to... Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to advancing peptide-based drug therapies. The company's development pipeline features PXL01, currently undergoing Phase IIa studies for its potential in preventing post-surgical adhesions and scars, mitigating dermal scarring, and aiding hand tendon repair. Another key asset, LL-37, is engaged in Phase IIb clinical trials to address venous leg ulcers, stimulate the healing of persistent wounds, and treat diabetic foot ulcers. Additionally, Promore Pharma has partnered with Fidia Farmaceutici S.p.A. for the production of hyaluronic acid syringes. Founded in 2002, the company, formerly known as Lipopeptide AB until its rebranding in January 2017, maintains its headquarters in Solna, Sweden.
Aandeelprijs
$1.34
Laatst gesynchroniseerd: 2024-02-14
Marktkapitalisatie
$48.96M
Verandering (1 dag)
-12.94%
Verandering (1 jaar)
0.00%
Land
SE
Handel Promore Pharma AB (publ) (PROMO)

Categorie

Koersgeschiedenis voor Promore Pharma AB (publ) (PROMO)
Hoogste slotkoers: $2.11 op 2024-02-01

Laagste slotkoers: $179.71 op 2017-07-01
Koersgeschiedenis van Promore Pharma AB (publ) van 2017 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2024 54.03%
2023 -86.45%
2022 -51.13%
2021 -52.08%
2020 -18.70%
2019 -67.83%
2018 -5.69%
2017 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$539.14 35.65%
US
$1.04K 56.21%
NL
$118.84 -18.14%
AU
$761.87 8.65%
CH
$130.43 397.46%
US